| Schedule of Segment Reporting Information, by Segment |
| | | | | | | | | | | | | | | Biopharmaceuticals | | Bioprocessing | | | | | Three Months Ended September 30, 2021 (in thousands) | | (iBio, Inc.) | | (iBio CDMO) | | Eliminations | | Total | | | | | | | | | | | | | | Revenues - external customers | | $ | 84 | | | 127 | | $ | — | | $ | 211 | Revenues - intersegment | | | 82 | | | 455 | | | (537) | | | — | Cost of goods sold | | | — | | | 40 | | | — | | | 40 | Gross profit | | | 166 | | | 542 | | | (537) | | | 171 | Research and development | | | 1,521 | | | 1,467 | | | (477) | | | 2,511 | General and administrative | | | 3,484 | | | 3,210 | | | (60) | | | 6,634 | Operating loss | | | (4,839) | | | (4,135) | | | — | | | (8,974) | Interest expense | | | — | | | (609) | | | — | | | (609) | Forgiveness of note payable and accrued interest | | | — | | | 607 | | | — | | | 607 | Interest and other income | | | 36 | | | — | | | — | | | 36 | Consolidated net loss | | | (4,802) | | | (4,138) | | | — | | | (8,940) | Total assets | | | 176,682 | | | 37,335 | | | (70,278) | | | 143,739 | Finance lease ROU assets | | | — | | | 25,695 | | | — | | | 25,695 | Operating lease ROU assets | | | 3,487 | | | — | | | — | | | 3,487 | Fixed assets, net | | | — | | | 9,821 | | | — | | | 9,821 | Intangible assets, net | | | 5,164 | | | — | | | — | | | 5,164 | Amortization of ROU assets | | | — | | | 416 | | | — | | | 416 | Depreciation expense | | | — | | | 306 | | | — | | | 306 | Amortization of intangible assets | | | 88 | | | — | | | — | | | 88 |
| | | | | | | | | | | | | | | Biopharmaceuticals | | Bioprocessing | | | | | Three Months Ended September 30, 2020 (in thousands) | | (iBio, Inc.) | | (iBio CDMO) | | Eliminations | | Total | | | | | | | | | | | | | | Revenues - external customers | | $ | 207 | | $ | 203 | | $ | — | | $ | 410 | Revenues - intersegment | | | 238 | | | 210 | | | (448) | | | — | Cost of goods sold | | | 54 | | | 53 | | | — | | | 107 | Gross profit | | | 338 | | | 413 | | | (448) | | | 303 | Research and development | | | 235 | | | 1,845 | | | (218) | | | 1,862 | General and administrative | | | 2,672 | | | 2,923 | | | (230) | | | 5,365 | Operating loss | | | (2,569) | | | (4,355) | | | — | | | (6,924) | Interest expense | | | — | | | (614) | | | — | | | (614) | Interest and other income | | | 3 | | | 1 | | | — | | | 4 | Consolidated net loss | | | (2,566) | | | (4,968) | | | — | | | (7,534) | Total assets | | | 132,207 | | | 33,320 | | | (48,272) | | | 117,255 | Finance lease ROU assets | | | — | | | 27,201 | | | — | | | 27,201 | Fixed assets, net | | | — | | | 3,834 | | | — | | | 3,834 | Intangible assets, net | | | 1,236 | | | — | | | — | | | 1,236 | Amortization of ROU assets | | | — | | | 415 | | | — | | | 415 | Depreciation expense | | | — | | | 97 | | | — | | | 97 | Amortization of intangible assets | | | 72 | | | — | | | — | | | 72 |
|